The aim of this study was to investigate the effects of flunixin meglumine, either as a standalone treatment or in conjunction with alpha lipoic acid as a protective agent, on the levels of liver enzymes, hepatic and stomach oxidative status, pro-inflammatory cytokine levels, and tumor pathological alterations
These reductions represent among the most substantial liver fat decreases observed with pharmacological therapy
Michailidis M, Moraitou D, Tata DA, Kalinderi K, Papamitsou T, Papaliagkas V
These agents are known to decrease food intake and promote weight loss through delayed gastric emptying, enhanced satiety, and appetite suppression
If it is a plain oil-based extract, the formula may separate without a solubilizer